3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
7
Obesity
5
Colorectal Neoplasms
5
Breast Neoplasms
4
Stroke
3
Motor Activity
3
Malnutrition
3
Hypertension
3
Diabetes Mellitus
3
Prostatic Neoplasms
2
Overweight
2
Osteoporosis
2
Kidney Diseases
2
Heart Failure
2
Frailty
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Cachexia
2
Arthritis
2
Weight Loss
1
Thinness
1
Stomach Neoplasms
1
Solid Tumors
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Sarcopenia
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Overnutrition
1
Interventions
Resistance Training
3
Exercise
2
Docosahexaenoic Acids
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
Ultrasonography
1
Standard of Care
1
Preoperative Exercise
1
Olive Oil
1
Nutritional Status
1
Nutrition Assessment
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Hepatectomy
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Gastrectomy
1
Esophagectomy
1
Drug Therapy
1
Control Groups
1
Colectomy
1
Chemotherapy, Adjuvant
1
CP protocol
1
4-azidosalicylic acid-phosphatidylserine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcopenia
×
Nutrition Assessment
×
Clear all
NCT07558486
2026-04-30
JMC-PHOU
Jimma University
Phase NA
Completed
104 enrolled